CBC Healthcare Infrastructure Platform (CBC HIP), a prominent independent life science real assets investor in China, has reportedly closed its second funding round at USD 875 million for its inaugural life science real assets venture, CLSRA Venture I. This significant milestone includes the participation of Abu Dhabi-based sovereign investor Mubadala Investment Company, alongside existing investors Dutch pension fund APG Asset Management and CBC Group.
Vision and Leadership
Hans Kang, Chief Executive Officer of CBC HIP, stated, “We will continue to tap the immense potential of life science real assets as a critical component of China’s growing healthcare and life science industry.” This vision underscores CBC HIP’s commitment to fostering innovation and expansion within the sector.
CLSRA Venture I: Scope and Impact
Founded in November 2021, CLSRA Venture I has quickly established itself with an impressive portfolio of approximately 520,000 square meters of life science real assets strategically located in Shanghai, Beijing, and Suzhou, China. These assets are poised to support the burgeoning healthcare and life science industry in the region, providing essential infrastructure for research, development, and commercialization of life-changing therapies and technologies.-Fineline Info & Tech
